Diagnostic value of combined detection of multiple serum cytokines for gastric adenocarcinoma
10.3872/j.issn.1007-385x.2020.04.011
- VernacularTitle:多种血清细胞因子联合检测对胃腺癌的诊断价值
- Author:
QI Yufeng
1
,
2
;
XU Kequn
1
,
2
;
ZHU Yingwei
1
,
2
;
SUN Junning
1
,
2
;
SU Wen
3
Author Information
1. 1. Department of Oncology, Changzhou No.2 People&rsquo
2. s Hospital, Changzhou 213000, Jiangsu, China
3. 2. Department of Immunology, Shanxi Cancer Hospital, Taiyuan 030013, Shanxi, China
- Publication Type:Journal Article
- Keywords:
gastric adenocarcinoma;
cytokines;
IL-8;
IL-6;
IL-10;
VEGF-A;
diagnosis;
progression
- From:
Chinese Journal of Cancer Biotherapy
2020;27(4):410-415
- CountryChina
- Language:Chinese
-
Abstract:
[Abstract] Objective:To explore the clinical significance of multiple serumcytokines in early diagnosis and progression assessment of gastric adenocarcinoma. Methods: Peripheral blood samples of 85 healthy subjects (healthy control group) and 81 patients with pathologically confirmed gastric adenocarcinoma (gastric cancer group) were collected from November 2017 to February 2018 at Shanxi Cancer Hospital. Serum levels of 17 cytokines (including IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-15, IL-17A, TNF-α, TNF-β, GM-CSF, G-CSF, IFN-γ, IP-10, MCP-1 andVEGF-A) were measured byAimPlex multiplex assay technology.Their diagnostic values were analyzed by receiver operating characteristic (ROC) curve. Results: Serum levels of IL-10, IL-8, IL-6, IP-10, MCP-1, VEGF-Aand IL-12p70 were significantly higher in gastric cancer patients than those in healthy controls (all P<0.01). There were significantly increasedlevelsofIL-8,IL-6and VEGF-Ain advanced-stage gastriccancer(stageI/II)groupoverearly-stage gastric cancer (stage III/IV) group (all P<0.01).AUC (areas under the curve) of IL-8, IL-6, IL-10, IP-10, MCP-1, IL-12p70 and VEGF-Afor distinguishing early-stage gastric cancer patientsfromhealthy controls was0.98,0.92,0.89,0.84,0.76,0.74 and 0.58, respectively. The diagnostic sensitivity of IL-8, IL-6 and IL-10 was 97.4%, 89.5% and 97.4%, respectively, and the specificity was 87.1%, 85.9%and 77.6%, respectively.TheAUCof IL-8, IL-6 andVEGF-Afor distinguishing advanced-stage gastric cancer patients from early-stage gastric cancer patients was 0.82, 0.72 and 0.69, respectively. Thediagnosticsensitivity of IL-8, IL-6 and VEGF-A was 83.7%, 60.5% and 41.9%, respectively, and the specificity was71.1%,76.3%and 92.1%, respectively. Conclusion: ThecombineddetectionofserumIL-8,IL-6andIL-10 may be a potential approach for early screening of gastric adenocarcinoma, which canalsobeusedtoassessthe progression of gastric adenocarcinoma.
- Full text:20200411.pdf
